Venture Challenge alumnus Incircular has received a convertible loan of € 300,000 from the Innovation Fund Noord-Holland for the development of its INCYPRO technology to stabilise proteins for pharmaceutical and diagnostic applications.
Last week, the Venture Challenge Summer 2021 kicked off with innovative Life Sciences & Health startups participating in the first bootcamp. The participating teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case.
SeraNovo BV is pleased to announce the closing of a License Agreement with Graviton Bioscience Corporation (Graviton), a biopharmaceutical company engaged in the research and development of small molecules in the fields of oncology and neuroscience.
Crown Bioscience (CrownBio), a JSR Life Sciences company and leader in preclinical services that help biopharmaceutical companies accelerate new drug development programs, has acquired OcellO B.V., a privately owned contract research organization located in the Netherlands.